1-5 of 5
Henrik Frederiksen, MD Prof
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Predictors of Response to Erythropoietin in Autoimmune Hemolytic Anemia

Bruno Fattizzo, MD, Marc Michel, Laetitia Languille, Juri Giannotta, MD, Henrik Frederiksen, MD Prof, Francesca Romana Mauro, MD, Bernd Jilma, Elisa Lucchini, MD, Andrea Patriarca, MD, Francesco Zaja, MD, Anita Hill, MD PhD, Sigbjorn Berentsen, MD PhD, Wilma Barcellini
Journal: Blood
Blood (2019) 134 (Supplement_1): 3516.
https://doi.org/10.1182/blood-2019-125524
Published: 2019
Journal Articles

Age and Time to Progression Predict Overall Survival (OS) in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Who Progress Following Frontline Immunochemotherapy (IC)

Matthew J. Maurer, MS, Lasse H. Jakobsen, PhD, Norbert Schmitz, MD, Umar Farooq, MD, Christopher R. Flowers, MD MS, Peter de Nully Brown, MD PhD, Carrie A. Thompson, MD, Henrik Frederiksen, MD Prof, David Cunningham, MD FRCP, FMedSci, Judit Jørgensen, MD PhD, Viola Poeschel, MD, Grzegorz Nowakowski, MD, John F. Seymour, MBBS, PhD FRACP, Francesco Merli, MD, Corinne Haioun, MD PhD, Herve Ghesquieres, MD PhD, Marita Ziepert, PhD, Herve Tilly, MD PhD, Gilles Salles, MD PhD, Qian Shi, PhD, Tarec Christoffer C. El-Galaly, MD, Thomas M. Habermann, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 400.
https://doi.org/10.1182/blood-2019-124017
Published: 2019
Journal Articles

Mapping Comorbidity in CLL: Impact on Prognostic Factors, Treatment Patterns and Causes of Death

Emelie Curovic Rotbain, MD, Carsten Utoft Niemann, MD PhD Ass. Prof, Klaus Rostgaard, MSc., Caspar Da Cunha-Bang, MD PhD, Henrik Hjalgrim, MD Dr.MD, Henrik Frederiksen, MD Prof
Journal: Blood
Blood (2019) 134 (Supplement_1): 4285.
https://doi.org/10.1182/blood-2019-122673
Published: 2019
Journal Articles

Venetoclax and Ibrutinib for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (R/R CLL) - 15-Month Safety, Response and MRD Evaluation: Third Interim Analysis from the Phase II Vision HO141 Trial

Carsten Utoft Niemann, MD PhD, Julie Dubois, Sabina Kersting, MD PhD, Lisbeth Enggaard, MD, Gerrit J Veldhuis, Rogier Mous, MD PhD, Clemens Mellink, PhD, Johan A Dobber, Christian Bjørn Poulsen, MD, Henrik Frederiksen, MD Prof, Ann Janssens, Ida Schjødt, MD PhD, Ellen C Dompeling, Juha Ranti, Mattias Mattsson, MD, Mar Bellido, Hoa T Tran, Kazem Nasserinejad, Mark-David Levin, MD PhD, Arnon P. Kater, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4292.
https://doi.org/10.1182/blood-2019-124377
Published: 2019
Journal Articles

Real-World Outcomes for 205 Danish Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib

Kathrine Aarup, Lisbeth Enggaard, MD, Robert Schou Pedersen, MD PhD, Rasmus Heje Thomsen, Olav Jonas Bergmann, Mikael Frederiksen, Ilse Christiansen, Tine Nielsen, Henrik Frederiksen, MD Prof, Carsten Utoft Niemann, MD PhD Ass. Prof, Michael Asger Andersen, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1767.
https://doi.org/10.1182/blood-2019-123011
Published: 2019